| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| HumanPheno | Abnormality of the forehead | 1.83e-05 | 1208 | 10 | 9 | HP:0000290 | |
| HumanPheno | Abnormal calvaria morphology | 2.53e-05 | 1254 | 10 | 9 | HP:0002683 | |
| Domain | DS_RBD | 5.14e-04 | 21 | 30 | 2 | PS50137 | |
| Domain | - | 8.54e-04 | 27 | 30 | 2 | 3.30.160.20 | |
| Domain | dsRBD_dom | 9.19e-04 | 28 | 30 | 2 | IPR014720 | |
| Domain | UBQ | 2.16e-03 | 43 | 30 | 2 | SM00213 | |
| Domain | ubiquitin | 2.58e-03 | 47 | 30 | 2 | PF00240 | |
| Domain | Ubiquitin-rel_dom | 3.14e-03 | 184 | 30 | 3 | IPR029071 | |
| Domain | UBIQUITIN_2 | 3.39e-03 | 54 | 30 | 2 | PS50053 | |
| Domain | Ubiquitin_dom | 3.90e-03 | 58 | 30 | 2 | IPR000626 | |
| Pathway | WP_EGFEGFR_SIGNALING | 1.76e-04 | 162 | 25 | 4 | M39334 | |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | 3.11e-04 | 188 | 25 | 4 | MM15828 | |
| Pubmed | Erk5 Is a Key Regulator of Naive-Primed Transition and Embryonic Stem Cell Identity. | 7.69e-07 | 2 | 31 | 2 | 27498864 | |
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 1592261 | ||
| Pubmed | 7.91e-06 | 143 | 31 | 4 | 32560809 | ||
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 1.06e-05 | 154 | 31 | 4 | 16055720 | |
| Pubmed | 2.58e-05 | 399 | 31 | 5 | 35987950 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | 2.90e-05 | 1038 | 31 | 7 | 26673895 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 2.97e-05 | 411 | 31 | 5 | 35182466 | |
| Pubmed | Multifaceted Regulation of Akt by Diverse C-Terminal Post-translational Modifications. | 3.23e-05 | 69 | 31 | 3 | 34941261 | |
| Pubmed | Pooled-matrix protein interaction screens using Barcode Fusion Genetics. | 3.25e-05 | 419 | 31 | 5 | 27107012 | |
| Pubmed | 3.35e-05 | 709 | 31 | 6 | 22988430 | ||
| Pubmed | A set of proteins interacting with transcription factor Sp1 identified in a two-hybrid screening. | 6.95e-05 | 14 | 31 | 2 | 10976766 | |
| Pubmed | 7.30e-05 | 497 | 31 | 5 | 23414517 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 7.30e-05 | 497 | 31 | 5 | 36774506 | |
| Pubmed | 1.30e-04 | 19 | 31 | 2 | 19115949 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 1.33e-04 | 565 | 31 | 5 | 25468996 | |
| Pubmed | High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface. | 1.55e-04 | 307 | 31 | 4 | 37499664 | |
| Pubmed | PTEN dephosphorylates Abi1 to promote epithelial morphogenesis. | 2.47e-04 | 26 | 31 | 2 | 32673396 | |
| Pubmed | Ankyrin repeats of ANKRA2 recognize a PxLPxL motif on the 3M syndrome protein CCDC8. | 2.86e-04 | 28 | 31 | 2 | 25752541 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 3.11e-04 | 148 | 31 | 3 | 32538781 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | 3.47e-04 | 695 | 31 | 5 | 23602568 | |
| Pubmed | Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM. | 3.99e-04 | 33 | 31 | 2 | 26864203 | |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | 4.14e-04 | 1124 | 31 | 6 | 21900206 | |
| Pubmed | Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing. | 4.68e-04 | 742 | 31 | 5 | 26871637 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 5.67e-04 | 774 | 31 | 5 | 15302935 | |
| Pubmed | 7.34e-04 | 463 | 31 | 4 | 27503909 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 8.20e-04 | 477 | 31 | 4 | 31300519 | |
| Pubmed | 8.50e-04 | 847 | 31 | 5 | 35850772 | ||
| Pubmed | 8.79e-04 | 486 | 31 | 4 | 20936779 | ||
| Interaction | GAS7 interactions | 2.84e-07 | 38 | 30 | 4 | int:GAS7 | |
| Interaction | PRPF40A interactions | 3.25e-06 | 446 | 30 | 7 | int:PRPF40A | |
| Coexpression | GSE37532_WT_VS_PPARG_KO_LN_TREG_UP | 5.36e-05 | 176 | 31 | 4 | M8952 | |
| Coexpression | GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_C57BL6_UP | 6.51e-05 | 185 | 31 | 4 | M8792 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_72H_CD8_T_CELL_UP | 8.81e-05 | 200 | 31 | 4 | M3648 | |
| Coexpression | GSE27786_CD4_VS_CD8_TCELL_UP | 8.81e-05 | 200 | 31 | 4 | M4819 | |
| Coexpression | GSE411_UNSTIM_VS_100MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN | 8.81e-05 | 200 | 31 | 4 | M6000 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.48e-06 | 182 | 31 | 4 | 4cd5eb13f78f4f377932c50ac2acb4ac0cd14c12 | |
| ToppCell | LA-14._Fibroblast_III|LA / Chamber and Cluster_Paper | 9.43e-06 | 193 | 31 | 4 | 7426c291bac59e539c427bcaae18abc7d397d44e | |
| ToppCell | LA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 9.63e-06 | 194 | 31 | 4 | 803fa83ceada17c38ca9f933b888f7e7b0b90761 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.02e-05 | 197 | 31 | 4 | b597c292fc1cb381a4325fed15a32966c38def28 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD8-Trm_gut_CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.04e-05 | 198 | 31 | 4 | aedd91e734bd919cf6b8c1586ad0cbd6e6d0f2ed | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.06e-05 | 199 | 31 | 4 | e245851a5bddf56f7e13a7fb7c5fda2fd275dae3 | |
| ToppCell | 15-Trachea-Immune-Immune|Trachea / Age, Tissue, Lineage and Cell class | 1.41e-04 | 146 | 31 | 3 | ca722a89c6601e78f253d9484d01931f26161820 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Fibroblasts-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.55e-04 | 151 | 31 | 3 | f13a117ae26ae525da4f3e837d8f204d00dc6ee3 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-HSC/ELP|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.59e-04 | 152 | 31 | 3 | f2cedf16e826aad763bfee5e46444327482f9a53 | |
| ToppCell | Control-Neu_1|Control / 5 Neutrophil clusters in COVID-19 patients | 1.72e-04 | 28 | 31 | 2 | eb8d8303c1a8f8f8cf9f8c2180406c06624690af | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.05e-04 | 166 | 31 | 3 | 1a3a15d1fc76bb91d832cdc6e3da0a6140b94b75 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Lymphocytic-T_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 169 | 31 | 3 | 630d921aa8fb5681d06a4e09b833855c374be484 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Lymphocytic-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 169 | 31 | 3 | 468284d4a3a0557aed04eadb1aba2317babc6904 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Lymphocytic|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 169 | 31 | 3 | 6f765e142d127545e622fe24b5287cd6e9706ccc | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-04 | 176 | 31 | 3 | 5201f003192c033655ba47f0faf8c47a96eae03d | |
| ToppCell | facs-Heart-RA-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-04 | 178 | 31 | 3 | b505e2550860e777535ee95f29c936242fd607f1 | |
| ToppCell | (1)_B_cells-(1)_B_CD27pos|(1)_B_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 2.65e-04 | 181 | 31 | 3 | d2476956ca13f9234d7e77c3ee432dd54eebeac4 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_T-T_NK-Treg|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.74e-04 | 183 | 31 | 3 | 5fb933acfe6bc555c90dba71e75d4be658763945 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.78e-04 | 184 | 31 | 3 | 23515c28e1f42aab29cef9e5b4a7f45bda7f5520 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-5_PVALB_TRIM67|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.78e-04 | 184 | 31 | 3 | 7f6c8912677764d438ab0555faca344d74c2f483 | |
| ToppCell | facs-Bladder-nan-18m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-04 | 185 | 31 | 3 | 3e00879466e626aa8604efecfc4678d64f54dbfc | |
| ToppCell | LPS-IL1RA-Myeloid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.82e-04 | 185 | 31 | 3 | 9b5fd87ea9d05e051ff1251578ecfbe5e8652853 | |
| ToppCell | facs-Bladder-nan-18m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-04 | 185 | 31 | 3 | 3dc5812c961ff209f197ff4cbfb90009c0537550 | |
| ToppCell | LPS-antiTNF-Myeloid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.87e-04 | 186 | 31 | 3 | 839c6da5244f469461b2e5563e36162b2911cd01 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.92e-04 | 187 | 31 | 3 | ba822dbceb47257129d6a8c9639c08d76de6d6a3 | |
| ToppCell | droplet-Skin-nan-21m-Lymphocytic|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-04 | 187 | 31 | 3 | ea33a5bd60b7f5f6d5b07a7f06a5a56395943641 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.92e-04 | 187 | 31 | 3 | 85f1678338a47d91e296f0620d4887f057eb7e70 | |
| ToppCell | droplet-Skin-nan-21m-Lymphocytic-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-04 | 187 | 31 | 3 | 38d7b19fde6811f5fbf548b2464486b197476dc6 | |
| ToppCell | droplet-Skin-nan-21m-Lymphocytic-T_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-04 | 187 | 31 | 3 | 1dbc2c0ab85033e5de776bbfdb73ebd3a50d2cc6 | |
| ToppCell | ILEUM-non-inflamed-(5)_Plasma-(5)_IgG_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.96e-04 | 188 | 31 | 3 | 2156f1bc849ff1cb09ae296d13bedd913ae6b43b | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-04 | 188 | 31 | 3 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.01e-04 | 189 | 31 | 3 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-04 | 190 | 31 | 3 | c247562df3e1aa3173c9f01a74d5831f0764a1b2 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-04 | 190 | 31 | 3 | 5cea8298c8336c136ba009630c9e48d4bc832cb2 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-04 | 191 | 31 | 3 | 297bc79adc5fef211497819b4861b52cd26ac754 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Occipital|World / Primary Cells by Cluster | 3.10e-04 | 191 | 31 | 3 | 467d6164aee7745d610cab512616dc7b69d2d8bd | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.10e-04 | 191 | 31 | 3 | 0b296404ebad0aadb75737f8c0462ec6934fc8bb | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-04 | 191 | 31 | 3 | e1ec165ba6578cefd88895e7e183190e79f733a4 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Occipital-15|World / Primary Cells by Cluster | 3.10e-04 | 191 | 31 | 3 | 190fadf6d7c5ba34d83ad6e5fa008451660db9cf | |
| ToppCell | facs-Skin-nan-18m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-04 | 192 | 31 | 3 | bae8df60440875fa04ff01e6c45214854dce0bc7 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.15e-04 | 192 | 31 | 3 | 1c0ce299cee9ab5cdea256f3e8c1e5598577a8b6 | |
| ToppCell | ASK428-Immune-T_cell|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.15e-04 | 192 | 31 | 3 | 121cb8c61002f20e1d287b8a7e67a30bb163e74a | |
| ToppCell | facs-Lung-nan-3m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-04 | 192 | 31 | 3 | cca2d0fedfbd946c54d6f4fc45887117c8dae58a | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 3.15e-04 | 192 | 31 | 3 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | facs-Skin-nan-18m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-04 | 192 | 31 | 3 | 3824d5b952be142ac5d13da1ef73813caf640f78 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.20e-04 | 193 | 31 | 3 | b9769b45125d2244afe53f9f71c92c04ddccf980 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.25e-04 | 194 | 31 | 3 | 3d6f2d190dd50804afea299957cc44c2bb756134 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.25e-04 | 194 | 31 | 3 | f64da5f62e29253d60b9546edf734ba5c17daae1 | |
| ToppCell | IPF-Stromal-Fibroblast|Stromal / Disease state, Lineage and Cell class | 3.25e-04 | 194 | 31 | 3 | da3e1d39575969a069ef43e552afe94b2f441d0b | |
| ToppCell | 356C-Myeloid-Monocyte-CD14+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.25e-04 | 194 | 31 | 3 | 3f9ac1de8605a7930f49a7ce0e32aea9997d7791 | |
| ToppCell | 356C-Myeloid-Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.25e-04 | 194 | 31 | 3 | a41cde3088b43670210daab4f43a24aa83dbd45b | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.25e-04 | 194 | 31 | 3 | 4eef50c38e6edb2ef2cdcd14eb50805f6cd65bc8 | |
| ToppCell | facs-Mammary_Gland|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-04 | 195 | 31 | 3 | 21cfcb751e548591fc8724a8329c294da6012e0f | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.34e-04 | 196 | 31 | 3 | fe8d3f45a64323947c36b127355d5940eb56c0ca | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.34e-04 | 196 | 31 | 3 | 526d037bb12d81f1c235c60ddc787fbad0bbad77 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.40e-04 | 197 | 31 | 3 | 340ce4fef244176fb52e38ffbcbdfda5ac3467dd | |
| ToppCell | wk_08-11-Hematologic-Myeloid-APOE+_Mac1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.40e-04 | 197 | 31 | 3 | 121ec3f6d978de2f6c2cc397f7327d2e5587ab8b | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.45e-04 | 198 | 31 | 3 | ec115c4a5dbc54206c72140aa0c8d6a7c29c5563 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-IPC_like|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 3.45e-04 | 198 | 31 | 3 | 6d12ecaa9532c134d9c4562534dcb59a6420b4d3 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 3.45e-04 | 198 | 31 | 3 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | moderate-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.45e-04 | 198 | 31 | 3 | 0a868098b1ee4b28b2149ed766acb09e9c0ce14c | |
| ToppCell | mLN-T_cell-Activated_CD4_T|T_cell / Region, Cell class and subclass | 3.45e-04 | 198 | 31 | 3 | 404ec46bd39b6f4d02a03ef38c30850bbbd8b608 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-IPC_like-IPs_and_early_cortical_neurons|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 3.45e-04 | 198 | 31 | 3 | 7943e4f67c3d6efb5c8b00aa0ff3cfe7be10c48d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.50e-04 | 199 | 31 | 3 | e7faf7d0cb43cf93149c446e5f718f84fa85477c | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.55e-04 | 200 | 31 | 3 | cc8368665bc6bb7c4f39632ccff07ceaa98a7b65 | |
| ToppCell | normal_Lung-Fibroblasts-COL14A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 3.55e-04 | 200 | 31 | 3 | 6d8f6a6b3f61c529fbed1376659641030abf4f2c | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid-Megakaryocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.55e-04 | 200 | 31 | 3 | 0d76b006d8e8b32174e65e400acd0674354b962c | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.55e-04 | 200 | 31 | 3 | ad0d38ffe5ca138b40823d15b239c2f9f3f0e93c | |
| Disease | Intellectual Disability | 9.58e-05 | 447 | 31 | 5 | C3714756 | |
| Disease | Bilateral Wilms Tumor | 4.26e-04 | 29 | 31 | 2 | C2930471 | |
| Disease | Nephroblastoma | 6.58e-04 | 36 | 31 | 2 | C0027708 | |
| Disease | S-warfarin measurement | 4.67e-03 | 97 | 31 | 2 | EFO_0803323 | |
| Disease | refractive error | 4.78e-03 | 326 | 31 | 3 | MONDO_0004892 | |
| Disease | Adenoid Cystic Carcinoma | 4.96e-03 | 100 | 31 | 2 | C0010606 | |
| Disease | eosinophil percentage of leukocytes | 7.41e-03 | 746 | 31 | 4 | EFO_0007991 | |
| Disease | Vertigo | 9.37e-03 | 139 | 31 | 2 | HP_0002321 | |
| Disease | Takayasu arteritis | 1.06e-02 | 148 | 31 | 2 | EFO_1001857 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PPPPPPPEPSDMPCA | 276 | P0C7U0 | |
| PPPPPPPPAPEQQTM | 661 | P46379 | |
| PPPPPPPPSMPQQAA | 776 | O60885 | |
| PELPPPPPDFMEPPP | 566 | Q7Z5R6 | |
| PPPDFMEPPPDFVPP | 571 | Q7Z5R6 | |
| MFDDSPPPPPPPPVD | 406 | Q8IZP0 | |
| DPRPPNPPKPMPNPN | 66 | P14209 | |
| PKPAEAPMPAEPAPP | 736 | Q9HBB8 | |
| PQTSQPPPPPPPMPF | 131 | Q96JC9 | |
| PPPPMARPVPLPVPD | 441 | Q12857 | |
| DSQREMPPPPPPSPP | 51 | P54829 | |
| MPPPPPPSPPSDPAQ | 56 | P54829 | |
| MESPPPAPPPCPGPA | 431 | Q13164 | |
| HPPPPGAPMAQPPTP | 111 | Q9UJ55 | |
| HPPPPGTPMAQPPAP | 221 | Q9UJ55 | |
| EEPVPGPMTPTQPPP | 886 | O15054 | |
| MPPMPSAPPVHPPPD | 1 | O60669 | |
| MSPEPVPPPPPPQCP | 1 | Q1L5Z9 | |
| MAEPPPPEPPAGPSE | 446 | Q08379 | |
| PQPPDPSQPPPGPMQ | 111 | O60927 | |
| PPPPSMAPPPPPVLE | 181 | Q5T0Z8 | |
| MAPPPPPVLEALSPP | 186 | Q5T0Z8 | |
| PPPPPNEINPPPHTM | 181 | P55010 | |
| RPSPEGDPSPPPPPM | 26 | Q3KQU3 | |
| PGPLRPMEEELPPPP | 156 | Q8WUP2 | |
| VTPAAAMEEPPPPPP | 16 | Q9Y6R4 | |
| PPPMPCPNNPPVPGA | 121 | Q9NRR4 | |
| MPAGPVQAVPPPPPV | 1 | Q15459 | |
| QKVPPPPETPMPPPL | 366 | Q15459 | |
| PPETPMPPPLPPTPD | 371 | Q15459 | |
| PPVAPVPAPAPMPPV | 656 | Q15459 | |
| VPAPAPMPPVHPPPP | 661 | Q15459 | |
| PMPPVHPPPPMEDEP | 666 | Q15459 | |
| EMPPPEPPEPPQEAA | 346 | Q9Y397 | |
| PPAPAPMPDPVVPPV | 196 | Q96JM2 | |
| MGSPPPPQPPPPDLS | 1096 | Q96JM2 | |
| EAPMAENPPPPPPPV | 6 | Q7RTV3 | |
| PEAMDPPPPKAPPFP | 16 | Q9UK33 | |
| PEEPPTMPPLPPEEP | 1151 | P18583 | |
| PPEEPPMTPPLPPEE | 1161 | P18583 | |
| PMTPPLPPEEPPEGP | 1166 | P18583 | |
| PESMDFPAQPPPPEP | 1171 | Q9BVV6 | |
| PPPPPPAPEEQDLSM | 711 | Q9P206 | |
| PPVPPQRPMAALPPP | 186 | Q13094 |